Narula Sanjeev (CIK 1820590) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-02). Recent activity: Buy PHAT (82,715 shares), Buy PHAT (144,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-02 | Phathom Pharmaceuticals, Inc. (PHAT) | Chief Financial & Bus. Officer | Buy | 82,715 | $0 |
| 2025-10-08 | Phathom Pharmaceuticals, Inc. (PHAT) | Chief Financial & Bus. Officer | Buy | 144,000 | $0 |
Source: SEC Form 4 filings · as of 2026-01-02